These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2124237)

  • 1. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.
    Starnes HF; Pearce MK; Tewari A; Yim JH; Zou JC; Abrams JS
    J Immunol; 1990 Dec; 145(12):4185-91. PubMed ID: 2124237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.
    Zanetti G; Heumann D; Gérain J; Kohler J; Abbet P; Barras C; Lucas R; Glauser MP; Baumgartner JD
    J Immunol; 1992 Mar; 148(6):1890-7. PubMed ID: 1541827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.
    Libert C; Vink A; Coulie P; Brouckaert P; Everaerdt B; Van Snick J; Fiers W
    Eur J Immunol; 1992 Oct; 22(10):2625-30. PubMed ID: 1327800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis.
    Hiromatsu T; Yajima T; Matsuguchi T; Nishimura H; Wajjwalku W; Arai T; Nimura Y; Yoshikai Y
    J Infect Dis; 2003 May; 187(9):1442-51. PubMed ID: 12717626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis.
    Lally KP; Cruz E; Xue H
    J Pediatr Surg; 2000 Jun; 35(6):852-4; discussion 855. PubMed ID: 10873025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lethal outcome caused by Porphyromonas gingivalis A7436 in a mouse chamber model is associated with elevated titers of host serum interferon-gamma.
    Huang JH; Lin YY; Lai YY; Hu SW
    Oral Microbiol Immunol; 2006 Apr; 21(2):100-6. PubMed ID: 16476019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-alpha.
    Jansen PM; de Jong IW; Hart M; Kim KJ; Aarden LA; Hinshaw LB; Taylor FB; Hack CE
    J Immunol; 1996 Jun; 156(11):4401-7. PubMed ID: 8666813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
    Pallua N; Low JF; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
    Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma involvement in the severity of gram-negative infections in mice.
    Kohler J; Heumann D; Garotta G; LeRoy D; Bailat S; Barras C; Baumgartner JD; Glauser MP
    J Immunol; 1993 Jul; 151(2):916-21. PubMed ID: 8335919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels.
    Kumar A; Haery C; Paladugu B; Kumar A; Symeoneides S; Taiberg L; Osman J; Trenholme G; Opal SM; Goldfarb R; Parrillo JE
    J Infect Dis; 2006 Jan; 193(2):251-8. PubMed ID: 16362889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine.
    Jesmok G; Lindsey C; Duerr M; Fournel M; Emerson T
    Am J Pathol; 1992 Nov; 141(5):1197-207. PubMed ID: 1443053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists.
    Zuckerman SH; Bryan-Poole N; Evans GF; Short L; Glasebrook AL
    Immunology; 1995 Sep; 86(1):18-24. PubMed ID: 7590877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
    Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ
    Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model.
    Emerson TE; Lindsey DC; Jesmok GJ; Duerr ML; Fournel MA
    Circ Shock; 1992 Oct; 38(2):75-84. PubMed ID: 1423924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte-derived cytokines augment macrophage tumor necrosis factor-alpha and interleukin-6 secretion during experimental gram-negative bacterial sepsis.
    Battafarano RJ; Kim SK; Dahlberg PS; Farber MS; Ratz CA; Johnston JW; Dunn DL
    J Surg Res; 1995 Jun; 58(6):739-45. PubMed ID: 7791354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent.
    Camargo CA; Madden JF; Gao W; Selvan RS; Clavien PA
    Hepatology; 1997 Dec; 26(6):1513-20. PubMed ID: 9397992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
    Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production.
    Diao H; Kohanawa M
    Infect Immun; 2005 Jun; 73(6):3745-8. PubMed ID: 15908405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.